Medical imaging reagents are chemicals used in imaging and detection technologies to visualize organs or structures. These reagents enable physicians to diagnose and detect diseases, thus playing a vital role in the healthcare and medical industry. The modern approach involves using these reagents in animal research before their reaction can be evaluated on humans. These reagents have addressed the increasing need for better therapeutics as they assist in detecting changes at the molecular level with the aid of X-ray and ultrasound. The global medical imaging reagents market was valued at $10,772 million in 2016, and is estimated to reach $18,587 million by 2023, registering a CAGR of 8.0% from 2017 to 2023.... Research Beam Model: Research Beam Product ID: 2019234 5370 USD New
Medical Imaging Reagents Market by Class (Contrast Reagents, Optical Reagents, and Nuclear Reagents), Technology (Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, and Quantum Dots), and Application (Diagnostics, Drug Discovery & Development, and R&D) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Toll Free : +1 (800)910-6452

 
 
PURCHASE OPTIONS
 

Medical Imaging Reagents Market by Class (Contrast Reagents, Optical Reagents, and Nuclear Reagents), Technology (Nanoparticles, Fluorescent Dyes & Probes, Radiopharmaceuticals, Fluorescent Proteins, and Quantum Dots), and Application (Diagnostics, Drug Discovery & Development, and R&D) - Global Opportunity Analysis and Industry Forecast, 2017-2023

 
  • Category : Healthcare
  • Published On : September  2017
  • Pages : 160
 
 

Medical imaging reagents are chemicals used in imaging and detection technologies to visualize organs or structures. These reagents enable physicians to diagnose and detect diseases, thus playing a vital role in the healthcare and medical industry. The modern approach involves using these reagents in animal research before their reaction can be evaluated on humans. These reagents have addressed the increasing need for better therapeutics as they assist in detecting changes at the molecular level with the aid of X-ray and ultrasound. The global medical imaging reagents market was valued at $10,772 million in 2016, and is estimated to reach $18,587 million by 2023, registering a CAGR of 8.0% from 2017 to 2023.

The global medical imaging reagents market is driven by rise in cases of chronic diseases such as cancer and cardiovascular diseases, increase in technological advancements, and high unmet medical and diagnostic imaging procedure needs. In addition, rise in geriatric population, increase in expenditure on healthcare, and growth in demand for effective procedures and safe medication are expected to fuel the market growth. However, lack of reagent suppliers and strict government regulations restrict this growth in developing regions.

The global medical imaging reagents market is segmented based on class, technology, application, and geography. Based on class, it is divided into contrast reagents, optical reagents, and nuclear reagents. The technology segment includes nanoparticles, fluorescent dyes & probes, radiopharmaceuticals, fluorescent proteins, and quantum dots. Based on application, the market is categorized into diagnostics, drug discovery & development, and R&D. Based on geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  •  This report offers a detailed quantitative analysis of the current market trends of the global medical imaging reagents market from 2016 to 2023 to identify the prevailing opportunities.
  •  The market estimations are based on comprehensive analysis of the key developments in the industry.
  •  In-depth analysis based on geography facilitates in analyzing the regional market to assist in strategic business planning.
  •  The development strategies adopted by key manufacturers are enlisted to understand the competitive market scenario.

KEY PLAYERS PROFILED

  •  Bracco Imaging SpA
  •  Bayer Healthcare AG
  •  Lantheus Medical Imaging, Inc.
  •  GE Healthcare
  •  Siemens Healthcare
  •  Covalon Technologies Ltd. 
  •  Thermo Fisher Scientific, Inc.
  •  Merck
  •  Philips Healthcare
  •  Shimadzu Corporation

KEY MARKET SEGMENTS

By Class

  •  Contrast Reagents
  •  Optical Reagents
  •  Nuclear Reagents

By Technology

  •  Nanoparticles
  •  Fluorescent Dyes & Probes
  •  Radiopharmaceuticals
  •  Fluorescent Proteins
  •  Quantum Dots

By Application

  •  Diagnostics
  •  Drug Discovery & Development
  •  R&D

By Geography

  •  North America
    •  U.S.
    •  Canada
    •  Mexico
  •  Europe
    •  Germany
    •  UK
    •  France
    •  Spain
    •  Rest of Europe
  •  Asia-Pacific
    •  Japan
    •  China
    •  Australia
    •  India
    •  Rest of Asia-Pacific
  •  LAMEA
    •  Brazil
    •  Republic of South Africa
    •  Saudi Arabia
    •  Rest of LAMEA

The other players of the dialysis market include (companies not profiled in the report):

  •  Guerbet Group
  •  Daiichi Sankyo
  •  nanoPET Pharma GmbH
  •  Subhra Pharma Private Limited
  •  CMC Contrast AB

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. PORTERS FIVE FORCES ANALYSIS
3.4. REGULATION AND REIMBURSEMENT SCENARIO
3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Growth in number of geriatric population
3.5.1.2. Increase in prevalence of chronic diseases
3.5.1.3. Rise in demand for diagnostic imaging procedures

3.5.2. Restraints

3.5.2.1. Shortage of supplies of imaging reagents
3.5.2.2. Stringent regulatory approvals
3.5.2.3. Reluctance in adopting nuclear reagents

3.5.3. Opportunities

3.5.3.1. Technological Advancements Leading
3.5.3.2. Development of personalized therapy
3.5.3.3. Untapped Markets in Developing Economies

CHAPTER 4 MEDICAL IMAGING REAGENTS MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. CONTRAST REAGENTS

4.2.1. Market size and forecast

4.3. OPTICAL REAGENTS

4.3.1. Market size and forecast

4.4. NUCLEAR REAGENTS

4.4.1. Market size and forecast

CHAPTER 5 MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. NANOPARTICLES

5.2.1. Market size and forecast

5.3. FLUORESCENT DYES & PROBES

5.3.1. Market size and forecast

5.4. RADIOPHARMACEUTICALS

5.4.1. Market size and forecast

5.5. FLUORESCENT PROTEINS

5.5.1. Market size and forecast

5.6. QUANTUM DOTS

5.6.1. Market size and forecast

CHAPTER 6 MEDICAL IMAGING REAGENTS MARKET, BY APPLICATIONS

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. DIAGNOSTICS

6.2.1. Market size and forecast

6.3. DRUG DISCOVERY & DEVELOPMENT

6.3.1. Market size and forecast

6.4. R&D

6.4.1. Market size and forecast

CHAPTER 7 MEDICAL IMAGING REAGENTS MARKET, BY GEOGRAPHY

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Mexico market size and forecast
7.2.3.3. Canada market size and forecast

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. UK market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. Germany market size and forecast
7.3.3.4. Rest of Europe market size and forecast

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. India market size and forecast
7.4.3.2. Japan market size and forecast
7.4.3.3. China market size and forecast
7.4.3.4. Rest of Asia-Pacific market size and forecast

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. South Africa market size and forecast
7.5.3.3. Saudi Arabia market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

CHAPTER 8 COMPANY PROFILES

8.1. BRACCO IMAGING SPA

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Business performance
8.1.5. Key strategic moves and developments

8.2. BAYER HEALTHCARE AG

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Business performance
8.2.5. Key strategic moves and developments

8.3. LANTHEUS MEDICAL IMAGING, INC.

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Business performance
8.3.5. Key strategic moves and developments

8.4. GE HEALTHCARE

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Business performance
8.4.5. Key strategic moves and developments

8.5. SIEMENS HEALTHCARE

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Business performance
8.5.5. Key strategic moves and developments

8.6. MALLINCKRODT PHARMACEUTICALS

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments

8.7. THERMO FISHER SCIENTIFIC, INC.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Business performance
8.7.5. Key strategic moves and developments

8.8. MERCK

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance
8.8.5. Key strategic moves and developments

8.9. BECTON DICKINSON & COMPANY

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Business performance
8.9.5. Key strategic moves and developments

8.10. CARDINAL HEALTH, INC.

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Business performance
8.10.5. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2016-2023 ($MILLION)
TABLE 2. MEDICAL IMAGING CONTRAST REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 3. MEDICAL IMAGING OPTICAL REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 4. MEDICAL IMAGING NUCLEAR REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 6. NANOPARTICLES MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 7. FLUORESCENT DYES & PROBES MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 8. RADIOPHARMACEUTICALS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 9. FLUORESCENT PROTEINS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 10. QUANTUM DOTS MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL MEDICAL IMAGING REAGENTS MARKET, BY APPLICATIONS, 2016-2023 ($MILLION)
TABLE 12. MEDICAL IMAGING REAGENTS MARKET FOR DIAGNOSTICS, BY REGION, 2016-2023 ($MILLION)
TABLE 13. MEDICAL IMAGING REAGENTS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2016-2023 ($MILLION)
TABLE 14. MEDICAL IMAGING REAGENTS MARKET FOR R&D, BY REGION, 2016-2023 ($MILLION)
TABLE 15. MEDICAL IMAGING REAGENTS MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 16. NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 17. NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2016-2023 ($MILLION)
TABLE 18. NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 19. NORTH AMERICA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATIONS, 2016-2023 ($MILLION)
TABLE 20. EUROPE MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 21. EUROPE MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2016-2023 ($MILLION)
TABLE 22. EUROPE MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 23. EUROPE MEDICAL IMAGING REAGENTS MARKET, BY APPLICATIONS, 2016-2023 ($MILLION)
TABLE 24. ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 25. ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2016-2023 ($MILLION)
TABLE 26. ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 27. ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, BY APPLICATIONS, 2016-2023 ($MILLION)
TABLE 28. LAMEA MEDICAL IMAGING REAGENTS MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 29. LAMEA MEDICAL IMAGING REAGENTS MARKET, BY CLASS, 2016-2023 ($MILLION)
TABLE 30. LAMEA MEDICAL IMAGING REAGENTS MARKET, BY TECHNOLOGY, 2016-2023 ($MILLION)
TABLE 31. LAMEA MEDICAL IMAGING REAGENTS MARKET, BY APPLICATIONS, 2016-2023 ($MILLION)
TABLE 32. BRACCO: COMPANY SNAPSHOT
TABLE 33. BRACCO: OPERATING SEGMENTS
TABLE 34. BAYER: COMPANY SNAPSHOT
TABLE 35. BAYER: OPERATING SEGMENTS
TABLE 36. LANTHEUS: COMPANY SNAPSHOT
TABLE 37. LANTHEUS: OPERATING SEGMENTS
TABLE 38. GE: COMPANY SNAPSHOT
TABLE 39. GE: OPERATING SEGMENTS
TABLE 40. SIEMENS: COMPANY SNAPSHOT
TABLE 41. SIEMENS: OPERATING SEGMENTS
TABLE 42. MALLINCKRODT: COMPANY SNAPSHOT
TABLE 43. MALLINCKRODT: OPERATING SEGMENTS
TABLE 44. THERMO FISHER: COMPANY SNAPSHOT
TABLE 45. THERMO FISHER: OPERATING SEGMENTS
TABLE 46. MERCK: COMPANY SNAPSHOT
TABLE 47. MERCK: OPERATING SEGMENTS
TABLE 48. BD: COMPANY SNAPSHOT
TABLE 49. BD: OPERATING SEGMENTS
TABLE 50. CARDINAL: COMPANY SNAPSHOT
TABLE 51. CARDINAL: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. SEGMENTATION OF GLOBAL MEDICAL IMAGING REAGENTS MARKET
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL MEDICAL IMAGING REAGENTS MARKET- 2016
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOP WINNING STRATEGIES: NATURE AND TYPE (2014-2016)
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY (2014-2016)
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. RESTRAINTS AND DRIVERS: GLOBAL MEDICAL IMAGING REAGENTS MARKET
FIGURE 12. U.S. MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 13. MEXICO MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 14. CANADA MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 15. UK MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 16. FRANCE MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 17. GERMANY MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 18. REST OF EUROPE MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 19. INDIA MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 20. JAPAN MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 21. CHINA MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 22. REST OF ASIA-PACIFIC MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 23. BRAZIL MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 24. SOUTH AFRICA MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 25. SAUDI ARABIA MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)
FIGURE 26. REST OF LAMEA MEDICAL IMAGING REAGENTS MARKET, 2016-2023 ($MILLION)